Nimbus Therapeutics
PrivateLast Round
VC Round
Sep 6, 2023
Total Funding Raised
$68.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Nimbus Therapeutics is a biotechnology company that develops small molecule compounds aimed at discovering innovative medicines and enhancing drug development for metabolic diseases, cancer, and immune-inflammatory disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nimbus Therapeutics Comparables
Compare Nimbus Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Antares Therapeutics | 85% | |
| Insitro | 83% | |
| HotSpot Therapeutics | 83% | |
Nimbus Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Sep 6, 2023 | ||||
| VC Round | Sep 12, 2022 | ||||
| VC Round | Jul 13, 2021 | ||||
| VC Round | Oct 14, 2020 | ||||
| VC Round | Jun 5, 2018 | ||||
Series B | Mar 18, 2015 |
Key People
Founding team and executive leadership
Nimbus Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Surveyor Capital | VC Round |
| Access Industries | VC Round |
| Bain Capital Life Sciences | VC Round |
| RA Capital Advisors | VC Round |
| RA Capital Management | VC Round |
| SV Health Investors | VC Round |
| GV | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2026
Presenting new data on SIK2 inhibitor program at IMMUNOLOGY2026.
- Mar 31, 2026
Announced new SIK2 inhibitors for autoimmune diseases, cancer, and diabetes.
Nimbus Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nimbus Therapeutics's valuation, stock price, and market status.